Identification of a Novel Small Molecule Facilitating HIV Elimination by the “Shock‐And‐Kill” Approach
Journal of Medical Virology · 2026
DOI: 10.1002/jmv.71131 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Yuichiro Hara und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Medicine, Institute of Science Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Virus Latency, HIV-1, Virus Activation, Anti-HIV Agents. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Agency for Medical Research and Development, Ministry of Education, Culture, Sports, Science and Technology, Japan Science and Technology Agency.
Abstract (Originalsprache)
Antiretroviral therapy (ART) has markedly improved the prognosis of people living with HIV (PLWH); however, latent viral reservoirs remain a major barrier to a cure. The “Shock and Kill” strategy aims to reactivate latent provirus with latency‐reversing agents (LRAs) and subsequently eliminate the infected cells, yet most LRAs characterized to date provide only the “shock” component. Through screening a small‐molecule library, we identified 2‐hydrido‐2,2'‐spirobi(1,3,2‐benzodioxaphosphole) (2‐HSB) as a novel candidate that both reactivates latent HIV provirus and selectively induces cytopathic effects in latently infected reservoir cell lines, thereby exhibiting a dual “Shock and Kill” activity within a single compound. Mechanistically, the HIV‐1 tat protein appears to contribute to this selectivity. At the single‐cell level, the two effects appeared largely independent, indicating that, under the conditions tested, reactivation was not a consequence of cell death and vice versa. Importantly, 2‐HSB induced viral transcription in ex vivo CD4 + T cells from ART‐suppressed PLWH. Together, these findings identify 2‐HSB as a dual‐action candidate that reactivates latent HIV‐1 and preferentially induces cytopathic effects in reservoir cell‐line models, while supporting further mechanistic and ex vivo validation in primary reservoir‐bearing cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Intensive Care Medicine, Institute of Science Tokyo, Tokyo, Japan.
- Department of High-risk Infectious Disease Control, Institute of Science Tokyo, Tokyo, Japan.
- Viral Biochemistry Section, Laboratory of Molecular Microbiology, NIAID, NIH, Bethesda, Maryland, USA.
- Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima, Japan.
- Department of Laboratory and Vascular Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
- Department of Molecular Virology, Institute of Science Tokyo, Tokyo, Japan.
ORCID-Profile: Yuichiro Hara, Haruki Kitamura, Kouki Matsuda, Chieko Fujisaki, Kosuke Tanimoto, Kenji Maeda, Hiroaki Takeuchi
Förderung
- Japan Agency for Medical Research and Development
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Science and Technology Agency
Zitieren
APA
Hara, Y., Kitamura, H., Matsuda, K., Fujisaki, C., Sukegawa, S., Tanimoto, K., Maeda, K., & Takeuchi, H. (2026). Identification of a Novel Small Molecule Facilitating HIV Elimination by the “Shock‐And‐Kill” Approach. Journal of Medical Virology. https://doi.org/10.1002/jmv.71131
Vancouver
Hara Y, Kitamura H, Matsuda K, Fujisaki C, Sukegawa S, Tanimoto K, et al. Identification of a Novel Small Molecule Facilitating HIV Elimination by the “Shock‐And‐Kill” Approach. Journal of Medical Virology. 2026. doi:10.1002/jmv.71131
BibTeX
@article{Hara2026,
author = {Hara, Yuichiro and Kitamura, Haruki and Matsuda, Kouki and Fujisaki, Chieko and Sukegawa, Sayaka and Tanimoto, Kosuke and Maeda, Kenji and Takeuchi, Hiroaki},
title = {Identification of a Novel Small Molecule Facilitating HIV Elimination by the “Shock‐And‐Kill” Approach},
journal = {Journal of Medical Virology},
year = {2026},
doi = {10.1002/jmv.71131}
}
EUVIMED